SYNH
Syneos Health Inc
Syneos Health Inc historical holders
total: 1
Viking Global Investors Syneos Health Inc transactions over time
- Total transactions:
- 9
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 4
- Held since:
- 2017 Q4
- Held for:
- 8 quarters
- Latest activity:
- 2019 Q4
Ole Andreas Halvorsen has been an institutional investor in Syneos Health Inc (SYNH) since 2017 Q4. According to 2026 Q1 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired SYNH in 2017 Q4, initially purchasing about 1.56M shares. Since the initial investment, Viking Global Investors has made 8 more transactions in this position.
When did Ole Andreas Halvorsen exit their SYNH position?
Ole Andreas Halvorsen no longer holds Syneos Health Inc (SYNH). They sold off their entire position in 2019 Q4, closing out an investment that began in 2017 Q4.
When did Ole Andreas Halvorsen first invest in SYNH?
Ole Andreas Halvorsen first invested in Syneos Health Inc (SYNH) in 2017 Q4 at the reported quarter-end price of $43.60 per share, acquiring 1,558,512 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for SYNH?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for Syneos Health Inc (SYNH) is approximately $44.04 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $44.04
- Weighted AVG sell price:
- $52.17
SYNH transactions history by Viking Global Investors
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$53.21
|
-100% (-575,847)
|
|||
|
2019 Q3
|
0.16%
|
$53.21
|
-67.95% (-1,220,928)
|
|||
|
2019 Q2
|
0.41%
|
$51.09
|
-19.03% (-422,299)
|
|||
|
2019 Q1
|
0.66%
|
$51.76
|
+26.35% (+462,724)
|
|||
|
2018 Q4
|
0.39%
|
$39.35
|
-2.65% (-47,754)
|
|||
|
2018 Q3
|
0.51%
|
$51.55
|
+1.77% (+31,323)
|
|||
|
2018 Q2
|
0.48%
|
$46.90
|
-7.93% (-152,767)
|
|||
|
2018 Q1
|
0.41%
|
$35.50
|
+23.55% (+367,036)
|
|||
|
2017 Q4
|
0.42%
|
$43.60
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.